{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:16:39Z","timestamp":1780503399955,"version":"3.54.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Q fever is a zoonotic disease caused by the highly infectious Gram-negative coccobacillus, <jats:italic>Coxiella burnetii<\/jats:italic> (<jats:italic>C. burnetii<\/jats:italic>). The Q fever vaccine Q-VAX<jats:sup>\u00ae<\/jats:sup> is characterised by high reactogenicity, requiring individuals to be pre-screened for prior exposure before vaccination. To date it remains unclear whether vaccine side effects in pre-exposed individuals are associated with pre-existing adaptive immune responses to <jats:italic>C. burnetii<\/jats:italic> or are also a function of innate responses to Q-VAX<jats:sup>\u00ae<\/jats:sup>. In the current study, we measured innate and adaptive cytokine responses to <jats:italic>C. burnetii<\/jats:italic> and compared these among individuals with different pre-exposure status. Three groups were included: n=98 Dutch blood bank donors with unknown exposure status, n=95 Dutch village inhabitants with known natural exposure status to <jats:italic>C. burnetii<\/jats:italic> during the Dutch Q fever outbreak of 2007-2010, and n=96 Australian students receiving Q-VAX<jats:sup>\u00ae<\/jats:sup> vaccination in 2021. Whole blood cytokine responses following <jats:italic>ex vivo<\/jats:italic> stimulation with heat-killed <jats:italic>C. burnetii<\/jats:italic> were assessed for IFN\u03b3, IL-2, IL-6, IL-10, TNF\u03b1, IL-1\u03b2, IP-10, MIP-1\u03b1 and IL-8. Serological data were collected for all three cohorts, as well as data on skin test and self-reported vaccine side effects and clinical symptoms during past infection. IFN\u03b3, IP-10 and IL-2 responses were strongly elevated in individuals with prior <jats:italic>C. burnetii<\/jats:italic> antigen exposure, whether through infection or vaccination, while IL-1\u03b2, IL-6 and TNF\u03b1 responses were slightly increased in naturally exposed individuals only. High dimensional analysis of the cytokine data identified four clusters of individuals with distinct cytokine response signatures. The cluster with the highest levels of adaptive cytokines and antibodies comprised solely individuals with prior exposure to <jats:italic>C. burnetii<\/jats:italic>, while another cluster was characterized by high innate cytokine production and an absence of <jats:italic>C. burnetii<\/jats:italic>-induced IP-10 production paired with high baseline IP-10 levels. Prior exposure status was partially associated with these signatures, but could not be clearly assigned to a single cytokine response signature. Overall, Q-VAX<jats:sup>\u00ae<\/jats:sup> vaccination and natural <jats:italic>C. burnetii<\/jats:italic> infection were associated with comparable cytokine response signatures, largely driven by adaptive cytokine responses. Neither individual innate and adaptive cytokine responses nor response signatures were associated retrospectively with clinical symptoms during infection or prospectively with side effects post-vaccination.<\/jats:p>","DOI":"10.3389\/fimmu.2022.886698","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T05:29:36Z","timestamp":1655962176000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Natural Exposure- and Vaccination-Induced Profiles of Ex Vivo Whole Blood Cytokine Responses to Coxiella burnetii"],"prefix":"10.3389","volume":"13","author":[{"given":"Susan","family":"Raju Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Scholzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazel","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Dzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowland","family":"Cobbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Poznansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Garritsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Sluder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000357107","article-title":"Coxiella Burnetii - Pathogenic Agent of Q (Query) Fever","volume":"41","author":"G\u00fcrtler","year":"2014","journal-title":"Transfusion Med Hemother"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/br.25.3.285-293.1961","article-title":"Airborne Q Fever","volume":"25","author":"Tigertt","year":"1961","journal-title":"Bacteriol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(03)00804-1","article-title":"Q Fever: A Biological Weapon in Your Backyard","volume":"3","author":"Madariaga","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268812001203","article-title":"Screening for Coxiella Burnetii Seroprevalence in Chronic Q Fever High-Risk Groups Reveals the Magnitude of the Dutch Q Fever Outbreak","volume":"141","author":"Kampschreur","year":"2013","journal-title":"Epidemiol Infect"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2014.02.006","article-title":"Q Fever in the Netherlands - 2007-2010: What We Learned From the Largest Outbreak Ever","volume":"44","author":"Schneeberger","year":"2014","journal-title":"Med Maladies Infect"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00045-16","article-title":"From Q Fever to Coxiella Burnetii Infection: A Paradigm Change","volume":"30","author":"Eldin","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.4.518","article-title":"Q Fever","volume":"12","author":"Maurin","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"B8","first-page":"1","article-title":"Diagnosis and Management of Q Fever\u2013United States, 2013: Recommendations From CDC and the Q Fever Working Group","volume":"62","author":"Anderson","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00185-12","article-title":"Prevalence of Chronic Q Fever in Patients With a History of Cardiac Valve Surgery in an Area Where Coxiella Burnetii is Epidemic","volume":"19","author":"Kampschreur","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1749-6632.1990.tb42203.x","article-title":"The Role of Lipopolysaccharides in the Virulence of Coxiella Burnetii","volume":"590","author":"Hackstadt","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1128\/jb.160.3.994-1002.1984","article-title":"Chemical and Immunological Characterization of Lipopolysaccharides From Phase I and Phase II Coxiella Burnetii","volume":"160","author":"Amano","year":"1984","journal-title":"J Bacteriol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/0008-6215(96)87610-5","article-title":"Structural Study on a Lipopolysaccharide From Coxiella Burnetii Strain Nine Mile in Avirulent Phase II","volume":"283","author":"Toman","year":"1996","journal-title":"Carbohydr Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006922","article-title":"Genetic Mechanisms of Coxiella Burnetii Lipopolysaccharide Phase Variation","volume":"14","author":"Beare","year":"2018","journal-title":"PloS Pathog"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.7.1823-1834.1998","article-title":"Diagnosis of Q Fever","volume":"36","author":"Fournier","year":"1998","journal-title":"J Clin Microbiol"},{"key":"B15","year":""},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146819","article-title":"Q Fever Knowledge, Attitudes and Vaccination Status of Australia\u2019s Veterinary Workforce in 2014","volume":"11","author":"Sellens","year":"2016","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.09.061","article-title":"Adverse Events and Association With Age, Sex and Immunological Parameters of Q Fever Vaccination in Patients at Risk for Chronic Q Fever in the Netherlands 2011","volume":"32","author":"Schoffelen","year":"2014","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1017\/S0950268812000404","article-title":"Time-Course of Antibody Responses Against Coxiella Burnetii Following Acute Q Fever","volume":"141","author":"Teunis","year":"2013","journal-title":"Epidemiol Infect"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1128\/iai.31.2.641-645.1981","article-title":"Role of Antibody in Coxiella Burnetii Infection","volume":"31","author":"Humphres","year":"1981","journal-title":"Infect Immun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.12.8372","article-title":"Mechanisms of Vaccine-Induced Protective Immunity Against Coxiella Burnetii Infection in BALB\/c Mice","volume":"179","author":"Zhang","year":"2007","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01767-06","article-title":"T Cells are Essential for Bacterial Clearance, and Gamma Interferon, Tumor Necrosis Factor Alpha, and B Cells are Crucial for Disease Development in Coxiella Burnetii Infection in Mice","volume":"75","author":"Andoh","year":"2007","journal-title":"Infect Immun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00101-10","article-title":"Role of CD4+ and CD8+ T Cells in Clearance of Primary Pulmonary Infection With Coxiella Burnetii","volume":"78","author":"Read","year":"2010","journal-title":"Infect Immun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00613-12","article-title":"Long-Term Immune Responses to Coxiella Burnetii After Vaccination","volume":"20","author":"Kersh","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701811","article-title":"Whole Blood Interferon \u03b3 Release Is a More Sensitive Marker of Prior Exposure to Coxiella Burnetii Than Are Antibody Responses","volume":"12","author":"Scholzen","year":"2021","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268808001908","article-title":"Investigation of a Q Fever Outbreak in a Rural Area of The Netherlands","volume":"137","author":"Karagiannis","year":"2009","journal-title":"Epidemiol Infect"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268815002472","article-title":"The Health Status of a Village Population, 7 Years After a Major Q Fever Outbreak","volume":"144","author":"Morroy","year":"2016","journal-title":"Epidemiol Infect"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00207","article-title":"Promiscuous Coxiella Burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine","volume":"10","author":"Scholzen","year":"2019","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131777","article-title":"Population Screening for Chronic Q-Fever Seven Years After a Major Outbreak","volume":"10","author":"Morroy","year":"2015","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0812074106","article-title":"Host Cell-Free Growth of the Q Fever Bacterium Coxiella Burnetii","volume":"106","author":"Omsland","year":"2009","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-4315-1_11","article-title":"Axenic Growth of Coxiella Burnetii","volume":"984","author":"Omsland","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"B31","volume-title":"Requirements For The Development And Use Of In-House In Vitro Diagnostic Medical Devices (IVDs)","year":"2018"},{"key":"B32","doi-asserted-by":"crossref","unstructured":"McInnesL\n            HealyJ\n            MelvilleJ\n          UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction2018","DOI":"10.21105\/joss.00861"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit129","article-title":"Specific Interferon \u03b3 Detection for the Diagnosis of Previous Q Fever","volume":"56","author":"Schoffelen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2014.12.008","article-title":"Early Cytokine and Antibody Responses Against Coxiella Burnetii in Aerosol Infection of BALB\/c Mice","volume":"81","author":"Schoffelen","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(84)91617-9","article-title":"Vaccine Prophylaxis of Abattoir-Associated Q Fever","volume":"2","author":"Marmion","year":"1984","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1994.tb125909.x","article-title":"Vaccine Prophylaxis of Q Fever. A Follow-Up Study of the Efficacy of Q-Vax (CSL) 1985-1990","volume":"160","author":"Ackland","year":"1994","journal-title":"Med J Aust"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu526","article-title":"Recognition of Coxiella Burnetii by Toll-Like Receptors and Nucleotide-Binding Oligomerization Domain-Like Receptors","volume":"211","author":"Ammerdorffer","year":"2015","journal-title":"J Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00898-15","article-title":"Roles of Toll-Like Receptor 2 (TLR2), TLR4, and MyD88 During Pulmonary Coxiella Burnetii Infection","volume":"84","author":"Ramstead","year":"2016","journal-title":"Infect Immun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3695","article-title":"Lipopolysaccharide From Coxiella Burnetii is Involved in Bacterial Phagocytosis, Filamentous Actin Reorganization, and Inflammatory Responses Through Toll-Like Receptor 4","volume":"172","author":"Honstettre","year":"2004","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1355.025","article-title":"TLR2 is Necessary to Inflammatory Response in Coxiella Burnetii Infection","volume":"1063","author":"Meghari","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00333-18","article-title":"Viable Coxiella Burnetii Induces Differential Cytokine Responses in Chronic Q Fever Patients Compared to Heat-Killed Coxiella Burnetii","volume":"86","author":"Jansen","year":"2018","journal-title":"Infect Immun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/j.celrep.2019.08.004","article-title":"\u03b2-Glucan-Induced Trained Immunity Protects Against Leishmania Braziliensis Infection: A Crucial Role for IL-32","volume":"28","author":"dos Santos","year":"2019","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining Trained Immunity and its Role in Health and Disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2014.00182","article-title":"Coxiella Burnetii Lipopolysaccharide Blocks P38\u03b1-MAPK Activation Through the Disruption of TLR-2 and TLR-4 Association","volume":"4","author":"Conti","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0501863102","article-title":"Virulent Coxiella Burnetii Does Not Activate Human Dendritic Cells: Role of Lipopolysaccharide as a Shielding Molecule","volume":"102","author":"Shannon","year":"2005","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-10-244","article-title":"Coxiella Burnetii Nine Mile II Proteins Modulate Gene Expression of Monocytic Host Cells During Infection","volume":"10","author":"Mahapatra","year":"2010","journal-title":"BMC Microbiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1993.tb08226.x","article-title":"Variation in Interferon-Gamma Responses to Coxiella Burnetii Antigens With Lymphocytes From Vaccinated or Naturally Infected Subjects","volume":"94","author":"Izzo","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.08.008","article-title":"Limited Humoral and Cellular Responses to Qfever Vaccination in Older Adults With Risk Factors for Chronic Q Fever","volume":"67","author":"Schoffelen","year":"2013","journal-title":"J Infect"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12423","article-title":"A Combination of Interferon-Gamma and Interleukin-2 Production by Coxiella Burnetii-Stimulated Circulating Cells Discriminates Between Chronic Q Fever and Past Q Fever","volume":"20","author":"Schoffelen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-19-3-281","article-title":"Antibody Responses in Acute and Chronic Q Fever and in Subjects Vaccinated Against Q Fever","volume":"19","author":"Worswick","year":"1985","journal-title":"J Med Microbiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268800059458","article-title":"Vaccine Prophylaxis of Abattoir-Associated Q Fever: Eight Years\u2019 Experience in Australian Abattoirs","volume":"104","author":"Marmion","year":"1990","journal-title":"Epidemiol Infect"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.4.781","article-title":"Markers of Cell-Mediated Immunity After Vaccination With an Inactivated, Whole-Cell Q Fever Vaccine","volume":"157","author":"Izzo","year":"1988","journal-title":"J Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.11.008","article-title":"Effectiveness of the Q Fever Vaccine: A Meta-Analysis","volume":"29","author":"Gefenaite","year":"2011","journal-title":"Vaccine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.886698\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T05:29:44Z","timestamp":1655962184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.886698\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2022.886698"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.886698","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"article-number":"886698"}}